The European Commission and German health technology assessors have poured cold water on aspirations by European Medicines Agency head Guido Rasi to introduce an adaptive licensing approach for evaluating and approving medicines.
Adaptive licensing – under which drugs would be approved earlier on than at present and on the basis of less...